2014

Cepheid to Webcast Upcoming Financial Presentations

SUNNYVALE, Calif., April 26, 2012 /PRNewswire/ -- Cepheid (NASDAQ: CPHD) today announced that its executives will be speaking at the following investor conferences, and invited investors to participate via webcast.


Deutsche Bank Health Care Conference, Boston, MA


Wednesday, May 9, 2012 at 10.00 a.m. Eastern Time




Baird Growth Conference, Chicago, IL


Thursday, May 10, 2012 at 9.30 a.m. Central Time




Bank of America Merrill Lynch Healthcare Conference, Las Vegas, NV


Thursday, May 17, 2012 at 9.20 a.m. Pacific Time




Jefferies Global Healthcare Conference, New York, NY


Tuesday, June 5, 2012 at 10.30 a.m. Eastern Time




Goldman Sachs Healthcare Conference, Rancho Palos Verdes, CA


Wednesday, June 6, 2012 at 10.40 a.m. Pacific Time




William Blair Growth Conference, Chicago, IL


Tuesday, June 12, 2012 at 11.30 a.m. Central Time

Accessing Live Webcasts

To access the live webcasts for these events, please visit Cepheid's website at www.cepheid.com/investors at least 15 minutes before the scheduled start time to download any necessary audio or plug-in software.  A replay of the webcasts will be available shortly following the presentation and will remain available for at least 90 days.

About Cepheid

Based in Sunnyvale, Calif., Cepheid (Nasdaq: CPHD) is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy to use molecular systems and tests. By automating highly complex and time-consuming manual procedures, the company's solutions deliver a better way for institutions of any size to access the full power of molecular diagnostics. The company's systems enable rapid, sophisticated genetic testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. Through its strong molecular biology capabilities, the company is focusing on those applications where accurate, rapid, and actionable test results are needed most, such as managing infectious diseases and cancer. For more information, visit www.cepheid.com.


CONTACTS:




For Media Inquiries:

For Investor Inquiries:







Jared Tipton

Cepheid Corporate Communications

Tel: (408) 400-8377

communications@cepheid.com

Jacquie Ross

Cepheid Investor Relations

Tel: (408) 400-8329

investor.relations@cepheid.com


 

SOURCE Cepheid



RELATED LINKS
http://www.cepheid.com

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.